Autoimmune Diseases  >>  AZD9056  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD9056 / AstraZeneca
NCT00520572 / 2007-001420-12: A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

Completed
2b
385
US, Canada, Europe, RoW
AZD9056, Etanercept, Placebo
AstraZeneca
Rheumatoid Arthritis
 
03/09

Download Options